Normal mammary gland tissue, mammary dysplasia, and benign tumors have been shown to have higher ER expression levels than malignant tumors (118, 127), with a recent study demonstrating that dogs with ER−/PR+ tumors had significantly worse survival rates in comparison to dogs with ER+/PR+ tumors. This evidence concerns the gene ESR1 and dysplasia.